Browse All

Current Filters

CLEAR FILTER x

TITLE

The MOXIe Trial of Omaveloxolone in Friedreich Ataxia: Exploring the Transient Nature of Treatment-emergent Adverse Events

Author:Lynch, David   Boesch, Sylvia   Delatycki, Martin   Giunti, Paola   Goldsberry, Angie   Hoyle, Chad   Mathews, Katherine   Khan, Seemi   Meyer, Colin   Murai, Masako   Nachbauer, Wolfgang   Perlman, Susan   Subramony, S   Zesiewicz, Theresa   

Session Name:P7: Movement Disorders: Ataxias 2  

Topic:Movement Disorders  

Program Number:P7.016  

Author Institution:The Children's Hospital of Philadelphia, Philadelphia, PA  Medical University of Innsbruck, Innsbruck, Austria  Murdoch Children's Research Institute, Parkville, Australia  University College London Hospital, London, United Kingdom  Reata Pharmaceuticals, Inc., Plano, TX  The Ohio State University, Columbus, OH  The University of Iowa , Iowa City, IA  University of California, Los Angeles, Los Angeles, CA  University of Florida Health, Gainesville, FL  University of South Florida Ataxia Research Center, Tampa, FL  

Diagnostic Yield of Genetic Testing Over Five Years in a Tertiary Ataxia Clinic

Author:Albertson, Richard   Paulson, Henry   Srinivasan, Sharan   Shakkottai, Vikram   Todd, Peter   

Session Name:P7: Movement Disorders: Ataxias 2  

Topic:Movement Disorders  

Program Number:P7.017  

Author Institution:University of Michigan, Ann Arbor, MI  University of Texas Southwestern Medical Center, Dallas, TX  

Psychometric Validation of the Modified-functional Scale for the Assessment and Rating of Ataxia

Author:Potashman, Michele   Popoff, Evan   Powell, Lauren   Beiner, Melissa   Mackenzie, Ainsley   Coric, Vladimir   Schmahmann, Jeremy   L'Italien, Gilbert   

Session Name:P7: Movement Disorders: Ataxias 2  

Topic:Movement Disorders  

Program Number:P7.018  

Author Institution:Biohaven Pharmaceuticals, Inc., New Haven, CT  Broadstreet HEOR, Vancouver, BC, Canada  Massachusettes General Hospital, Boston, MA  

Development of a Novel Composite Measure (SCACOMS) to Assess Disease Progression in Spinocerebellar Ataxia

Author:L'Italien, Gilbert   Popoff, Evan   Rogula, Basia   Potashman, Michele   Powell, Lauren   Beiner, Melissa   Coric, Vladimir   Perlman, Susan   Schmahmann, Jeremy   Hendrix, Suzanne   

Session Name:P7: Movement Disorders: Ataxias 2  

Topic:Movement Disorders  

Program Number:P7.019  

Author Institution:Biohaven Pharmaceuticals, Inc., New Haven, CT  Broadstreet HEOR, Vancouver, BC, Canada  UCLA School of Medicine, Los Angeles, CA  Massachusettes General Hospital, Boston, MA  Pentara Corporation, Millcreek, UT  

A Clinical Observational Study for Developing Disease Modifying Therapy Against Spinocerebellar Ataxia Type 31

Author:Ishikawa, Kinya   Aoki, Hanako   Honda, Takeru   Higashi, Miwa   Nagata, Tetsuya   Yokota, Takanori   

Session Name:P7: Movement Disorders: Ataxias 2  

Topic:Movement Disorders  

Program Number:P7.020  

Author Institution:Tokyo Medical and Dental University, Tokyo, Japan, Japan  Tokyo Medical and Dental University, Tokyo, Japan